dreamm-8: belantamab mafodotin pomalidomide and dex shows improved outcomes in rr multiple myeloma
Published 2 months ago • 378 plays • Length 15:46Download video MP4
Download video MP3
Similar videos
-
3:04
dreamm-3: belantamab mafodotin vs pom/dex for r/r myeloma
-
1:44
the role of belantamab mafodotin in multiple myeloma: the dreamm-7 and dreamm-8 trials
-
3:27
belantamab mafodotin, pomalidomide and dexamethasone shows superior efficacy in rrmm compared to...
-
1:02
dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
-
5:38
dreamm-6: safety and tolerability of belantamab mafodotin in combination with bortezomib/dex in rrmm
-
6:39
dreamm-9: belantamab mafodotin standard care in newly diagnosed multiple myeloma
-
3:59
dreamm-9: phase i study of belantamab mafodotin standard of care in pts w/transplant-ineligible ndmm
-
0:48
final analysis of the dreamm-2 trial: belantamab mafodotin for r/r multiple myeloma
-
4:58
dreamm-2: single-agent belantamab mafodotin in patients with rrmm and renal impairment
-
0:58
belantamab mafodotin: a potential new soc in second-line myeloma based on the dreamm trials
-
58:48
best of ash 2019
-
6:09
dreamm-2: effects of belantamab mafodotin on patient reported outcomes in myeloma
-
1:33
dreamm-9: phase iii study belantamab mafodotin plus vrd vs vrd alone in transplant-ineligible ndmm
-
1:41
elotuzumab plus pomalidomide and dexamethasone for multiple myeloma
-
1:16
treatment combinations being explored with belantamab mafodotin in multiple myeloma
-
1:51
an update on the use of belantamab mafodotin in multiple myeloma
-
3:10
what impact do revlimid® (lenalidomide) and pomalyst® (pomalidomide) have on the bone marrow?
-
6:42
dreamm-5 platform trial: belantamab mafodotin in combination with novel agents in patients with rrmm
-
4:45
iberdomide in combination with dex in pts with rrmm: results from the cc-220-mm-001 trial